Latest News

The company's dependable dividend remains safe.

The team discusses hot, upcoming IPOs and how investors should be thinking about managing their portfolios in light of these new, exciting opportunities.

Here's how these two ETF giants compare on key factors such as risk, returns, and diversification.

What 300-year-old investing principles still apply today? What can Teddy Roosevelt’s cattle farm disaster teach us about modern stock picking? Historian, investor, and author Dr. Joseph S. Moore joins the show to discuss his new book, How to Get Rich in American History.

Motley Fool retirement expert Robert Brokamp provides 11 tips for making the most of your employer-sponsored retirement plan.

AMD looks poised to be a huge agentic AI winner.

Infleqtion uses similar technology to IonQ. Could it really outperform?

Elon Musk’s empire may be expanding if recent plans to spend up to $119 billion in new chip fab facilities become reality. The team discusses the implications for the industry and Musk’s companies.

A larger lifetime benefit could be just one move away.

This ETF is beating the Nasdaq and the S&P 500.

EverQuote (NASDAQ:EVER) Chief Financial Officer Joseph Sanborn said the online insurance marketplace is benefiting from a healthier property and casualty insurance industry as carriers shift from restoring underwriting profitability to pursuing policy growth. Speaking with Needham & Company ana

A look beyond the most basic of numbers quickly makes one of these a more reliable long-term income prospect.

After seeing enough demand, ARM Holdings said they, too, are getting into the semiconductor manufacturing business.

Top Wall Street analysts have maintained their bullish S&P 500 Index forecasts, pointing to the ongoing corporate earnings growth

The short-term risks of SoundHound's acquisition of LivePerson are weighing on the stock price.

Occidental Petroleum has multiple upside catalysts.

The conglomerate's first portfolio disclosure under its new CEO hints at a willingness to lean further into technology.

Micron's rally has been nothing short of incredible.

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and colorectal cancers during a Bank of America biotech conference session. Jonathan Lim, Erasca’s chair

The business is thriving, so why is the stock down?

The Roundhill Memory ETF (CBOE: DRAM) continued its strong momentum last week, helped by the strong demand for memory products as the artificial intelligence (AI) boom continued.

Lucid's robotaxi partnership with Uber and Nuro moved closer to launch after executive Nick Twork shared his first autonomous ride experience.

Kevin Warsh is taking the reins at the Federal Reserve.

ACI Worldwide delivers digital payments and real-time transaction solutions for banks, merchants, and billers worldwide.